1. Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy
   Caiqiong Liu et al, 2021, Frontiers in Pharmacology CrossRef
2. SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization
   Wojciech Wiertelak et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
3. T lymphocytes in IgA nephropathy (Review)
   Yuyan Tang et al, 2020, Experimental and Therapeutic Medicine CrossRef
4. MiR‐320 promotes B cell proliferation and the production of aberrant glycosylated IgA1 in IgA nephropathy
   Chunmei Li et al, 2018, Journal of Cellular Biochemistry CrossRef
5. Quantitative assessment of successive carbohydrate additions to the clusteredO-glycosylation sites of IgA1 by glycosyltransferases
   Tyler J Stewart et al, 2021, Glycobiology CrossRef
6. C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy
   Yue Xing et al, 2020, BMC Nephrology CrossRef
7. T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target
   Jakub Ruszkowski et al, 2019, Clinical and Experimental Nephrology CrossRef
8. CDG and immune response: From bedside to bench and back
   Carlota Pascoal et al, 2020, Journal of Inherited Metabolic Disease CrossRef
9. Mutual regulation between glycosylation and transforming growth factor-β isoforms signaling pathway
   Zhuo Chen et al, 2023, International Journal of Biological Macromolecules CrossRef